Optimal Voluntary Vaccination of Adults and Adolescents Can Help Eradicate Hepatitis B in China

Autor: Jan Rychtář, Ayesha Ejaz, Kristen Scheckelhoff, Dewey Taylor, Igor V. Erovenko

Publikováno v: Games
Volume 12
Issue 4
Games, Vol 12, Iss 82, p 82 (2021)

Hepatitis B (HBV) is one of the most common infectious diseases, with a worldwide annual incidence of over 250 million people. About one-third of the cases are in China. While China made significant efforts to implement a nationwide HBV vaccination p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7b1091324a891ba5cef6a1408a4d4e

Evaluating the independent influence of sexual transmission on HBV infection in China: a modeling study

Autor: Jian Zu, Mingwang Shen, Guihua Zhuang, Hui Zheng, Miaolei Li, Siyuan Chen, Guomin Zhang, Fuzhen Wang

Publikováno v: BMC Public Health
BMC Public Health, Vol 21, Iss 1, Pp 1-10 (2021)

BackgroundThe long-term impact of sexual transmission on the hepatitis B virus (HBV) infection in China remains unclear. This study aims to estimate the independent influence of sexual transmission on HBV infection.MethodsBased on the natural history

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574fb8c75b47140a2da1eb45ed3580da
https://doi.org/10.1186/s12889-021-10408-5

Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning

Autor: Po-Lin Chan, Lan Zhang, Daniel Low-Beer, Hui Zhuang, Yue Xiao, Lai Wei, Wang Ailing, Yu Wang, Nick Walsh, Lance E. Rodewald, Xiaochun Wang, Guomin Zhang, Mark Thursz, Shevanthi Nayagam, Joo H Chang, Yingpeng Qiu, Timothy B. Hallett, Bernhard Schwartländer, Binyan Sui, Kun Zhao, Weiwei Hou, Elisa Sicuri, Fabio Scano, Jidong Jia

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

Background In 2016, the first global viral hepatitis elimination targets were endorsed. An estimated one-third of the world’s population of individuals with chronic hepatitis B virus (HBV) infection live in China and liver cancer is the sixth leadi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce94ba8fb68e582a048cf73fb71147f9
http://hdl.handle.net/2445/162677

Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model

Autor: Fuqiang Cui, Hui Zheng, Fuzhen Wang, Peifeng Liang, Guihua Zhuang, Jian Zu, Xiaofeng Liang

Publikováno v: Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Scientific Reports

The age-specific seroclearance pattern of hepatitis B surface antigen (HBsAg) in chronic hepatitis B virus (HBV) infections of China remains unclear. In this study, based on three national serosurvey data of hepatitis B in China, we propose an age- a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::830ce9b544f1002afa7a0a368de91612
https://doaj.org/article/e309c2187c534e8eb45419548cdd361a

Effects of traditional Chinese medicine formula Le-Cao-Shi on hepatitis B: In vivo and in vitro studies

Autor: Shi-Jun Yue, Min Chen, Meng-Qi Zhang, Qing Zhao, Ren Xia, Yue-Wei Guo, Chang-Yun Wang, Kai-Xian Chen, Chang-Lun Shao

Publikováno v: Journal of ethnopharmacology. 244

Ethnopharmacological relevance Formula Le-Cao-Shi (LCS) is a traditional Chinese medicine (TCM), which has long been used as a folk remedy against hepatitis B in China. The present study was conducted to evaluate the anti-hepatitis B effects of aqueo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3835089349930e8596a00ef7e45ed360
https://pubmed.ncbi.nlm.nih.gov/31381954